Multiply Labs Inc. today announced an agreement with AstraZeneca to evaluate the potential for applying good manufacturing practice, or GMP-ready, robotic systems to commercial-scale cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results